Format

Send to:

Choose Destination
See comment in PubMed Commons below
Pharmacogenomics. 2011 Oct;12(10):1485-92. doi: 10.2217/pgs.11.95.

Pharmacogenetics in randomized controlled trials: considerations for trial design.

Author information

  • 1Julius Center for Health Sciences & Primary Care, University Medical Center Utrecht, Stratenum 6.131, Utrecht, The Netherlands. f.vanderbaan@umcutrecht.nl

Abstract

Pharmacogenetic analyses of clinical trials aim to either detect whether a subgroup of patients identified by genetic characteristics responds differently to the treatment or to verify whether a proposed genotype-guided treatment is beneficial over standard care. This article describes three different trial designs, differing in the timing of randomization and genotyping. Each design has its own advantages, and the objectives and conditions under which each one is most suited are discussed.

PMID:
22008051
[PubMed - indexed for MEDLINE]
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Full text links

    Icon for Atypon
    Loading ...
    Write to the Help Desk